Posted on 1/20/21
Simione Healthcare Consultants Promotes Robert V. Simione, CPA, as Principal
William J. Simione, III, Managing Principal, Simione Healthcare Consultants, has announced the promotion of Robert V. Simione, CPA, as a Principal with the firm following 11 . . .
Posted on 1/20/21
Sixth Street to Acquire Talcott Resolution
Talcott Resolution Life Insurance Company today announced that Sixth Street, a leading global investment firm, has entered into a definitive agreement to acquire the company
Posted on 1/20/21
Iora Health Strengthens Executive Team
Iora Health, a leading transformer of the healthcare industry, today announced the addition of two leaders to round out their Executive Team. Gillian Munson, Chief Financial . . .
Posted on 1/20/21
Ribbon Appoints Tom Berry as Vice President
Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications software and IP optical transport solutions to service providers, enterprises, and critical infrastructure sectors, . . .
Posted on 1/20/21
Haemonetics To Acquire Cardiva Medical
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered . . .
Posted on 1/20/21
Land & Buildings Sends Letter to Apartment Income REIT Board of Directors
STAMFORD, Conn.--(BUSINESS WIRE)--Today Land & Buildings Investment Management LLC, a significant shareholder of Apartment Income REIT (NYSE: AIRC), sent a letter to the Company’s Board of Directors.The . . .
Posted on 1/20/21
Frank Neumann, M.D., Ph.D., to Depart Verastem Oncology
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the departure of . . .
Posted on 1/20/21
RMR Mortgage Trust Provides $10.9 Million First Mortgage Bridge Loan for the Acquisition of an Office Building in Miami, FL
NEWTON, Mass.--(BUSINESS WIRE)--RMR Mortgage Trust (Nasdaq: RMRM) today announced the closing of a $10.9 million first mortgage bridge loan it provided to finance the acquisition of . . .
Posted on 1/20/21
Aldeyra Therapeutics Closes of Public Offering of Common Stock
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives . . .
Posted on 1/20/21
Meketa Investment Group Appoints Amy Hsiang as Director
BOSTON--(BUSINESS WIRE)--Meketa Investment Group, a global investment consulting and fiduciary management (OCIO) firm, today announced the hiring of Amy Hsiang as Director of Public Markets Manager . . .
Posted on 1/20/21
Talaris Therapeutics Appoints Sapna Srivastava and Gaurav Shah to its Board of Directors
Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential to induce durable immune tolerance across a range
Posted on 1/20/21
Cohere Capital Invest in CCS
BOSTON--(BUSINESS WIRE)--Cohere Capital, a Boston-based private equity firm focused on investing in leading tech-enabled middle market companies, announced that it has made a strategic growth investment . . .
Posted on 1/20/21
Syros Prices of $75.6 Million Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, announced today that it has priced an . . .
Posted on 1/20/21
First Eagle Alternative Credit COO & CFO Terry Olson to Retire
BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- First Eagle Alternative Credit, LLC today announced that Terry Olson, chief operating officer and chief financial officer, has elected . . .
Posted on 1/20/21
Fort Point Capital Raises Fund II With $194 Million
BOSTON--(BUSINESS WIRE)--Fort Point Capital, a leading private equity firm focused on investing in service-oriented companies in the lower middle market, announced today that it has completed . . .
Posted on 1/20/21
Black Diamond Therapeutics Appoints Dr. Kapil Dhingra to Board
CAMBRIDGE, Mass. and NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and . . .
Posted on 1/20/21
AVEO Oncology Announces Incremental $10M Loan
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced that it has received a commitment letter for an incremental $10 million loan from Hercules Capital, Inc. (NYSE: HTGC) . . .
Posted on 1/20/21
Imara Appoints Kenneth Attie, M.D. as Chief Medical Officer
BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering . . .
Posted on 1/20/21
Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous
In this video from Motley Fool Live, recorded on Jan. 4, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss upcoming . . .
Posted on 1/20/21
Moderna CEO's 9 Words That Could Mean Billions for the Biotech
Moderna (NASDAQ:MRNA) generated revenue of roughly $60 million in 2019. The company will post total revenue measured in the hundreds of millions of dollars for 2020. . . .
Posted on 1/20/21
Fulcrum Therapeutics Prices of Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically . . .
Posted on 1/20/21
TCR Therapeutics Prices Public Offering of $140.0 Million of Common Stock
CAMBRIDGE, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for . . .
Posted on 1/20/21
Editas Medicine Announces Offering of Common Stock
CAMBRIDGE, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced that it intends to offer and . . .
Posted on 1/20/21
Oyster Enterprises Acquisition Corp. Prices $200M IPO
STAMFORD, Conn.--(BUSINESS WIRE)--Oyster Enterprises Acquisition Corp. announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit.The units have been approved for . . .
Posted on 1/20/21
Nilesh Patel Joins Cellanyx Board of Directors
Cellanyx today announced that Nilesh Patel has been appointed to the Cellanyx board of directors. Nilesh is a private equity executive with an extensive background in . . .
Boston
